Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination.
about
Broad Spectrum Anticancer Activity of Myo-Inositol and Inositol HexakisphosphateChemoprevention of lung cancer: prospects and disappointments in human clinical trialsChemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonismPhenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms.Combinations of indole-3-carbinol and silibinin suppress inflammation-driven mouse lung tumorigenesis by modulating critical cell cycle regulators.¹H NMR-based metabolic profiling of human rectal cancer tissueTargeted regulation of PI3K/Akt/mTOR/NF-κB signaling by indole compounds and their derivatives: mechanistic details and biological implications for cancer therapyCombinatorial strategies employing nutraceuticals for cancer development.Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease.Nanoparticles increase the efficacy of cancer chemopreventive agents in cells exposed to cigarette smoke condensate.Indole-3-Carbinol and Its Role in Chronic Diseases.Lunasin-aspirin combination against NIH/3T3 cells transformation induced by chemical carcinogens.Scientific Opinion on the safety and efficacy of inositol as a feed additive for fish, dogs and catsPredictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study.
P2860
Q28078208-343A6006-AA70-4C2F-AE60-7E9ACE4B9AACQ28386632-FAD2CEF7-778C-4473-B02E-C5D0554B7DA7Q33716515-D83BD75D-9E07-4A0A-96F0-05F0C71F2B09Q34079481-9096749C-1647-46F0-A95C-AE720D4E59F1Q34663720-9938186B-336F-4353-A1A4-5E6B50F490CFQ36067911-F16A2B87-0B57-484E-80DE-2556A00ED0F8Q37285687-668FA940-FB2D-4BFF-A875-0A7BEFF990BFQ37512204-CB3B7BAE-4973-4A87-9AAD-DDD963DC0CEEQ37906730-683A9A8B-5925-452E-B674-603C09E54334Q38879505-72C33DB4-AACB-454F-B040-034763EB3882Q38912777-5A638CB7-E513-4B10-A1D3-BA61D8D5F0B1Q38965200-0439A523-06FB-4AB1-BA1A-D7BF70A7EFE2Q39544493-A3593000-1FAC-47D7-B72A-0B2576CA5D20Q47154490-2859E211-9D37-45A5-97AE-F7D3E8DF46EAQ49569229-AB90C8B0-CA26-4C25-8227-E7769C85B44A
P2860
Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Inhibition of lung carcinogene ...... tol, alone and in combination.
@ast
Inhibition of lung carcinogene ...... tol, alone and in combination.
@en
Inhibition of lung carcinogene ...... tol, alone and in combination.
@nl
type
label
Inhibition of lung carcinogene ...... tol, alone and in combination.
@ast
Inhibition of lung carcinogene ...... tol, alone and in combination.
@en
Inhibition of lung carcinogene ...... tol, alone and in combination.
@nl
prefLabel
Inhibition of lung carcinogene ...... tol, alone and in combination.
@ast
Inhibition of lung carcinogene ...... tol, alone and in combination.
@en
Inhibition of lung carcinogene ...... tol, alone and in combination.
@nl
P2093
P2860
P356
P1433
P1476
Inhibition of lung carcinogene ...... tol, alone and in combination.
@en
P2093
Abaineh Endalew
Fekadu Kassie
Pramod Upadhyaya
Stephen S Hecht
Tamene Melkamu
Xianghua Luo
P2860
P304
P356
10.1093/CARCIN/BGQ139
P407
P577
2010-07-05T00:00:00Z